Immunity is complicated. Immfinity lets our partners see clearly.
We use our T cell epitope sequencing (Tope-seq) system to discover T cell receptor antigens and decode reactivity
Our technology is based on real cells. We do functional assays based on directly testing millions of T cell epitopes simultaneously. No guesswork.
At Immfinity, we profile off-target autoreactivity to enable TCR engineering with confidence, do multiplexed TCR discovery using libraries of interesting targets instead of picking just one, and perform fine epitope mapping.
We de-risk and accelerate early discovery and development in TCR based therapeutics and peptide-coding vaccines, preventing catastrophic failures in the clinic and making sure resources go towards advancing only the best medicines.
Company Details
- Employees
- 2
- Address
- Vancouver, British Columbia, Ca
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.immfinity.com
- Keywords
- North Vancouver.
- HQ
- Vancouver, British Columbia
Immfinity Biotechnologies Questions
Immfinity Biotechnologies's website is http://www.immfinity.com
Immfinity Biotechnologies's LinkedIn profile is https://ca.linkedin.com/company/immfinity-biotechnologies
Immfinity Biotechnologies has
2 employees.
View email and phone details for 2
employees at Immfinity Biotechnologies.
Immfinity Biotechnologies's industry is
Biotechnology Research
Immfinity Biotechnologies's top competitors are
Sgc Digital Media,
Toolkit For The Future,
Collingwood Automations,
Ccrw | Ccrt,
Bc Cancer,
Ginger Desk,
Evolved Therapeutics,
Immfinity Gmbh,
Blanka,
Indievision.
Immfinity Biotechnologies's categories are Biotechnology Research
